Pluri Inc.PLUREarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Shayna LP | 8.10% | 3.4M | ▼ -0.60pp | 2024-02-13 |
| Regals Capital Management LP | 4.87% | 2.0M | — | 2024-02-01 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.